Madeline Carrellas

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

J. Korzenik, J. Marchesi, Sonia C. Timberlake, 2019, The American journal of gastroenterology.

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.

I. García-Pérez, J. Marchesi, K. Kennedy, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Bile Acid Profiles are Not Altered by Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis: Category Award (Liver): Presidential Poster Award

J. Korzenik, J. Marchesi, Sonia C. Timberlake, 2018, American Journal of Gastroenterology.

Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery

J. Korzenik, E. Barnes, E. Collins, 2016, Digestive Diseases and Sciences.

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

C. Kelly, J. Marchesi, B. Mullish, 2020, Inflammatory bowel diseases.

Higher 25‐hydroxyvitamin D levels are associated with greater odds of remission with anti‐tumour necrosis factor‐α medications among patients with inflammatory bowel diseases

J. Korzenik, E. Collins, R. Winter, 2017, Alimentary pharmacology & therapeutics.